Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort-Reference-Cited by-同舟云学术

Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort

Published:2022-04 Issue:4 Volume:6 Page:e12705
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Boyce Sara^ORCID,James Izabela,Rangarajan Savita,Curry Nicola,Bagot Catherine^ORCID,Austin Steven,Laffan Mike,Mangles Sarah,Chandrakumaran Kandiah,Mundy Carina

Funder

Sangamo Therapeutics

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12705

Reference27 articles.

1. Guidelines on the use of prophylactic factor replacement for children and adults with haemophilia A and B;Rayment;Br J Haematol,2020

2. Advances and challenges for hemophilia gene therapy;Batty;Hum Mol Genet,2019

3. Inhibitors in haemophilia: what have we learned from registries? A systematic review;Osooli;J Intern Med,2015

4. Identifying and overcoming barriers to prophylaxis in the management of haemophilia;Petrini;Haemophilia,2007

5. Gene therapy for hemophilia;Chuah;J Thromb Haemost,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding AAV vector immunogenicity: from particle to patient;Theranostics;2024

2. Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy;Molecular Therapy;2023-03

3. Multiplexing AAV Serotype-Specific Neutralizing Antibodies in Preclinical Animal Models and Humans;Biomedicines;2023-02-11